𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Azathioprine. Safety profile in multiple sclerosis patients

✍ Scribed by L. La Mantia; N. Mascoli; C. Milanese


Publisher
Springer Milan
Year
2007
Tongue
English
Weight
92 KB
Volume
28
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Influence of azathioprine (Imuran) on in
✍ Dr. Joel J.-F. Oger; Jack P. Antel; Han Hwa Kuo; Barry G. W. Arnason πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 488 KB πŸ‘ 2 views

## Abstract In vitro immune function was assessed in patients with multiple sclerosis (MS) who were receiving Imuran therapy, in untreated MS patients, and in controls. In untreated stable MS patients, concanavalin A (Con A)‐driven mitogenic reactivity (T effector function) and Con A‐induced suppre

Azathioprine in multiple sclerosisβ€”A 3 y
✍ U. Patzold; P. Pocklington πŸ“‚ Article πŸ“… 1980 πŸ› Springer 🌐 English βš– 895 KB

The results of a prospective, long-term controlled study on the treatment of multiple sclerosis with azathioprine are reported. The effect of a daily 2 mg/kg body weight dosage on 56 randomly chosen patients with multiple sclerosis is compared with a non-treated control group of 51 randomly selected